Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial Meeting Abstract


Authors: Carvajal, R. D.; Agulnik, M.; Ryan, C. W.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H. A. H.; Elias, A. D.; Read, W. L.; Budd, G. T.; Hirman, J.; Weiden, P.; Bennett, C. M.; Livingston, P. O.; Hansen, D.; Maki, R. G.; Schwartz, G. K.; Chugh, R.
Abstract Title: Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204653
PROVIDER: wos
Notes: Meeting Abstract: 10520 -- Source: Wos
MSK Authors
  1. Gary Schwartz
    364 Schwartz
  2. Richard D Carvajal
    133 Carvajal
  3. Robert Maki
    211 Maki
Related MSK Work